Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 934 participants.

Also called NCT01700439

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 934 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01700439
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01700439. Allocation not applicable; no masking; primary purpose treatment. Start 2012-09-26 (actual); primary completion 2021-05-26 (actual). Results posted on 2017-12-13.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Surgical Treatment of Aortic Stenosis With a Next Generation, Rapid Deployment Surgical Aortic Valve
Acronym
TRANSFORM™
Condition
Aortic Valve Stenosis
Condition
Aortic Valve Stenosis With Insufficiency
Condition
Regurgitation, Aortic Valve
Condition
Aortic Valve Incompetence
Intervention (Device)
EDWARDS INTUITY valve
Lead sponsor
Edwards Lifesciences (class: industry)

Record details

Record id
cardio:ct-nct01700439
Content hash
fe4e96f6d9a2ff4fabe6154c084957e9b22fa229cd68c4ee7d5485ccc99954b8